The Uromigos Episode 174: Cell-Free DNA as a Biomarker in Bladder Cancer

By The Uromigos - Last Updated: June 4, 2022

Amir Goldkorn, MD, discusses translational findings from a phase 2 bladder trial, SWOG data about predicting response to neoadjuvant chemotherapy, and more.

Post Tags:Uromigos-ASCO
Did you like this article?